Nautilus Biotechnology, Inc. NAUT
Set alert
2.34 USD -0.40 -14.47%
At close
2.32 -0.02 -0.70%
Pre-market · Nov 3, 6:20 AM ET
2.27 Day range 2.75
0.841 52-week range 4.31
- YTD
- +19.74%
- 1 year
- +26.22%
- Open
- 2.74
- Prev close
- 2.73
- Mkt cap
- 297.41M
- Vol
- 7.30M
- Avg vol
- 5.35M
- EPS
- -0.46
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.27
- High
- 2.75
- Forward P/E
- -2.32
- Beta
- 1.04
- Short ratio
- 9.26
- Inst. own
- 50.19%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jul 30, 2024
- 50-d avg
- 2.42
- 200-d avg
- 2.56
- 1y target
- 3.44
MAX chart
Events in this range
- Jul 14, 2022Rating: Goldman Sachs · — → Neutral
- Aug 3, 2022Rating: Goldman Sachs · — → Neutral
- Aug 3, 2022Rating: Morgan Stanley · — → Equal-Weight
- Aug 3, 2023Rating: Morgan Stanley · Equal-Weight → Equal-Weight
- Feb 28, 2024Earnings: -0.14; estimate -0.16; surprise 12.5%
- Apr 30, 2024Earnings: -0.15; estimate -0.16; surprise 6.25%
- Apr 30, 2024Earnings: —; estimate -0.16; surprise —%
- Jun 27, 2024Rating: Guggenheim · — → Buy
- Jul 30, 2024Earnings: -0.14; estimate -0.16; surprise 12.5%
- Jul 30, 2024Earnings: —; estimate -0.16; surprise —%
- Oct 29, 2024Earnings: -0.13; estimate -0.17; surprise 23.53%
- Dec 5, 2024Downgrade: Goldman Sachs · Neutral → Sell
Signals (97)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 5, 2026 | 4 weeks ago |
| SMA: Bullish | Sep 28, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 28, 2026 | 1 month ago |
| RSI: Oversold | Aug 3, 2026 | 3 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| MACD: Sell Signal | Apr 27, 2026 | 6 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| RSI: Overbought | Mar 16, 2026 | 7 months ago |
| RSI: Overbought | Feb 16, 2026 | 8 months ago |
| SMA: Bullish | Feb 2, 2026 | 9 months ago |
| SMA: Bearish | Jan 26, 2026 | 9 months ago |
| SMA: Bullish | Jan 19, 2026 | 9 months ago |
| SMA: Bearish | Jan 12, 2026 | 9 months ago |
| RSI: Overbought | Nov 3, 2025 | 1 year ago |
| SMA: Bullish | Sep 22, 2025 | 1 year ago |
| SMA: Bullish | Sep 22, 2025 | 1 year ago |
| SMA: Bearish | Aug 4, 2025 | 1 year ago |
| SMA: Bullish | Jul 21, 2025 | 1 year ago |
| SMA: Bearish | Jul 14, 2025 | 1 year ago |
| SMA: Bullish | Jun 30, 2025 | 1 year ago |
Newest 20 of 97.
Analyst view
Consensus: buy
Buy
Price target (mean) 3.44 +47.2% upside
Now 2.34
- Target (low)
- 1.75
- Target (mean)
- 3.44
- Target (high)
- 5.00
Ratings (0m) 5 2 buy · 2 hold · 1 sell
- Strong buy0
- Buy2
- Hold2
- Sell0
- Strong sell1
Recommendation trend
- This month 5
- 1 month ago 5
- 2 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.16333 | -0.18 – -0.15 | -0.14 | -16.7% | 0 | 0.0% | 3 |
| Next quarter | -0.18 | -0.20 – -0.15 | -0.15 | -20.0% | 0 | 0.0% | 3 |
| Current year | -0.58333 | -0.60 – -0.57 | -0.51 | -14.4% | 0 | 0.0% | 3 |
| Next year | -0.74333 | -0.84 – -0.66 | -0.58333 | -27.4% | 3.62M | 0.0% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 5, 2024 | Goldman Sachs | Downgrade | Neutral | Sell |
| Jun 27, 2024 | Guggenheim | Initiated | — | Buy |
| Aug 3, 2023 | Morgan Stanley | Reiterated | Equal-Weight | Equal-Weight |
| Aug 3, 2022 | Morgan Stanley | Maintained | — | Equal-Weight |
| Aug 3, 2022 | Goldman Sachs | Maintained | — | Neutral |
| Jul 14, 2022 | Goldman Sachs | Maintained | — | Neutral |
| Apr 13, 2022 | Goldman Sachs | Maintained | — | Neutral |
| Jan 6, 2022 | Morgan Stanley | Initiated | — | Equal-Weight |
| Nov 2, 2021 | Cowen & Co. | Initiated | — | Outperform |
| Aug 4, 2021 | Goldman Sachs | Initiated | — | Neutral |
| Jul 13, 2021 | Jefferies | Initiated | — | Buy |